HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognosis of occupational asthma induced by isocyanates.

Abstract
Several studies on the prognosis of isocyanate-induced asthma show that a significant proportion of patients continue to experience asthmatic symptoms and nonspecific bronchial hyperresponsiveness after cessation of work, and that further exposure to isocyanates in sensitized subjects leads almost invariably to persistence of respiratory symptoms and of bronchial hyperresponsiveness and the deterioration of airway function. Specific bronchial reactivity to isocyanates may change after cessation of work; however, some subjects continue to be sensitive to TDI several months after cessation of work. The determinants of an unfavourable prognosis for asthma seem to be the same as those for other types of occupational asthma due to low molecular weight compounds (i.e. red cedar asthma): long duration of exposure before the onset of asthma, long duration of symptoms before diagnosis, airway obstruction, and dual airway response after specific challenge tests. Also, single acute exposure to high levels of TDI in the workplace (spills) can result in persistent nonspecific bronchial hyperresponsiveness. Potential mechanisms of persistence of symptoms and of nonspecific bronchial hyperresponsiveness may be chronic inflammation, bronchial smooth muscle alteration, autonomic nervous system disregulation.
AuthorsP L Paggiaro, E Bacci, F L Dente, D Talini, C Giuntini
JournalBulletin europeen de physiopathologie respiratoire (Bull Eur Physiopathol Respir) 1987 Nov-Dec Vol. 23 Issue 6 Pg. 565-9 ISSN: 0395-3890 [Print] England
PMID3331124 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Cyanates
Topics
  • Asthma (chemically induced, physiopathology)
  • Bronchi (physiopathology)
  • Bronchial Provocation Tests
  • Cyanates (adverse effects)
  • Follow-Up Studies
  • Forced Expiratory Volume
  • Humans
  • Occupational Diseases (chemically induced, physiopathology)
  • Prognosis
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: